All News

The Leap Motion Controller system used with serious games may be an effective option for a rehabilitation tool for improving coordination, speed of movements, and fine upper limb dexterity in patients with Parkinson disease, according to a recent study, published by the Journal of NeuroEngineering and Rehabilitation.

The November issue of The American Journal of Managed Care® (AJMC®) included studies on a kidney disease intervention, perceptions of alternative financing models, population health screening, and more. Here are 5 findings from research published in the issue.

In Australia, adults who are female, single, middle-aged, and have lower levels of education are more likely to experience less-than-optimal sleep, according to a recent study.

Called Diabetes Can Break Your Heart, the initiative seeks to get doctors and patients talking about the connection between diabetes and heart failure, so that symptoms are not missed and treatment that could prevent heart failure occurs early. A Diabetes Heartbreaker tour, which will feature a virtual reality experience with immersive technology, will kick off this weekend at the American Heart Association Scientific Sessions in Philadelphia.

Researchers aim to eliminate leukemia stem cells safely.

Solera announced this week that the company has expanded its relationship with Blue Mesa Health to offer a Spanish-language Diabetes Prevention Program (DPP) Transformemos as a covered California Medicaid (Medi-Cal) member benefit.

A team of researchers led by Memorial Sloan-Kettering Cancer Center Thursday published work describing how they used machine learning, a form of artificial intelligence (AI), to predict tumor type from targeted DNA sequence data to predict tissue of origin, in a finding that may have implications to improve diagnostic and clinical care.

Financial assistance provided to patients in California who require dialysis is being threatened amid a new state law; WHO to certify insulins to curb rising prices; CDC warns of rising drug-resistant superbug threat.

The EPA proposal to limit science used in rulemaking was discussed by panel members during a hearing held today by the House Committee on Science, Space, and Technology, with patient confidentiality serving as a major issue.

Regulators and lawmakers have expressed concern over possible privacy breaches as Google and Ascension collect healthcare data; Amarin’s Vascepa goes before an FDA committee this week; CMS Administrator Seema Verma defends Medicaid work requirements.

Greater rates of adherence and persistence seen among patients on a single-tablet regimen.

Secondary analyses of data from the landmark CREDENCE trial show that the protective renal benefits of the SGLT2 inhibitor canagliflozin are greatest among type 2 diabetes patients with lower kidney function.

Updated Carthadex trial results show improved responses at the 58-month mark and build on findings from other studies.

Researchers proposed new diagnostic criteria for chronic obstructive pulmonary disease (COPD) that seek to identify more patients in early stages of the disease, promote better care for patients, and stimulate research to slow and prevent COPD, in a paper published today in the journal Chronic Obstructive Pulmonary Diseases.

The use of wearable trackers found a link in patients reporting insufficient sleep with biological aging and increased risk of cardiovascular disease, according to study findings.

EPA's new draft of their science transparency rule expands limitations on the use of science for agency rulemaking; cannabis-based medicine approved by National Health Service in England and Wales; medical care for mental health is expanding among adolescents.

As healthcare companies, tech firms, and startups seek to use digital tools to help individuals manage their health, patients have growing concerns about how their data are used. During a panel discussion during the opening day of the FT Global Pharmaceutical and Biotechnology Conference 2019, held this week in London, United Kingdom, executives from across the pharmaceutical and digital health spaces discussed the critical importance of building relationships with patients as a means to not only reap high-quality data, but also improve patients’ outcomes and save healthcare systems money.

Hypertrophic cardiomyopathy is often an inherited condition and patients may not show symptoms, or those symptoms may be vague, such as fatigue or shortness of breath. The condition can cause varied levels of risk and can result in sudden cardiac death.

Kaiser Permanente chairman and chief executive officer Bernard J. Tyson dies at 60; vitamin E acetate is linked as a potential cause of vaping-related lung injuries; Medicare’s outpatient premium cost is rising.

The report emphasizes the need for maximizing the implementation and improving treatment and prevention tools to fight HIV because adherence challenges remain.

The age of psoriasis onset determines whether arthritis or psoriasis starts first in patients with psoriatic arthritis (PsA).

Perhaps not surprisingly, younger children had higher levels of parental support overall; the study also found that mothers provided more support than fathers.

An interim analysis of migraine drug erenumab showed that it continued to be safe and well-tolerated, with an adverse event profile consistent with those found in shorter-term placebo-controlled studies.

A recent study sought to identify an mRNA biomarker that predicts chemosensitivity across multiple solid tumor subtypes, given the significant heterogeneity in response among patients to chemotherapies.

For their study, the authors wanted to expand on previous research results that suggest outcomes are improved among patients with multiple myeloma treated at high-volume facilities.

Socially deprived patients were younger, more frequently women, active smokers, living alone, and belonged to lower socioprofessional categories when compared with the non-socially deprived group, but they still benefitted from home-based pulmonary rehabilitation.

Patients with diabetes who participated in a program of group medical visits (GMVs) and intensive weight management showed improvements in glycemic control, according to a study published in JAMA Internal Medicine.

The use of fluticasone-containing inhaled corticosteroids (ICS) was linked to increased risk of pneumonia in patients with COPD, according to study findings.